| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
IZABRIGHT-BREAST01 - A RANDOMIZED, OPEN-LABEL, INFERENTIALLY SEAMLESS PHASE 2/3 STUDY OF IZALONTAMAB BRENGITECAN (BMS-986507) VERSUS TREATMENT OF PHYSICIAN’S CHOICE IN PATIENTS WITH PREVIOUSLY UNTREATED, LOCALLY ADVANCED, RECURRENT INOPERABLE, OR METASTATIC TRIPLENEGATIVE BREAST CANCER (TNBC) OR ER-LOW, HER2-NEGATIVE BC WHO ARE INELIGIBLE FOR ANTI- PD1/PD-L1 TREATMENT |
II/III |
in corso |
CARCINOMA MAMMARIO |
- SC Oncologia Clinica Sperimentale di Senologia |
|
A MULTICENTRE, OPEN-LABEL, PHASE 3, RANDOMISED CONTROLLED TRIAL OF DUVELISIB VERSUS INVESTIGATOR’S CHOICE OF GEMCITABINE OR BENDAMUSTINE IN PATIENTS WITH RELAPSED/REFRACTORY NODAL T CELL LYMPHOMA WITH T FOLLICULAR HELPER (TFH) PHENOTYPE (TERZO) |
III |
in corso |
linfoma |
- SC Ematologia Oncologica |
|
STUDIO IN APERTO PER LA PROSECUZIONE DELL’ACCESSO AL TRATTAMENTO DI PARTECIPANTI PROVENIENTI DAGLI STUDI SU ENCORAFENIB E BINIMETINIB C4221016 E C4221023 - (PROTOCOLLO MASTER ENCORAFENIB/BINIMETINIB: UNO STUDIO DI PROSECUZIONE IN APERTO PER I PARTECIPANTI PROVENIENTI DAGLI STUDI CLINICI CON ENCORAFENIB/BINIMETINIB) |
II |
in corso |
MELANOMA |
- SC Oncologia Clinica Sperimentale del Melanoma – Immunoterapia e Terapie Innovative |
|
CIRCULATING EBV-DNA CHANGES IN TAILORING TREATMENT OF LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA: THE PHASE 2 TRIAL INTERLAYER |
NA |
in corso |
CARCINOMA NASOFARINGEO |
- SC Oncologia Clinica Sperimentale Testa – Collo |
|
A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE 2 STUDY EVALUATING THE SAFETY AND EFFICACY OF BMS-986504 MONOTHERAPY IN PARTICIPANTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) WITH HOMOZYGOUS MTAP DELETION AFTER PROGRESSION ON PRIOR THERAPIES |
II |
in corso |
CARCINOMA POLMONARE |
- SC Oncologia Clinica Sperimentale Toraco - Polmonare |
